Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
International journal of pharmaceutics
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/40886810/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266157488734209 |
|---|---|
| author | Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad |
| author_facet | Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad |
| collection | PubMed - marine biology |
| contents | Applications of artificial intelligence and nanotechnology in vaccine development. Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad Humans Artificial Intelligence Nanotechnology Vaccine Development COVID-19 Vaccines COVID-19 Animals Nanoparticles SARS-CoV-2 Vaccines have long been crucial in safeguarding public health by preventing and controlling infectious diseases. However, traditional vaccine development methods face challenges in efficiency, cost, and response time to emerging pathogens. Recent progress in art AI and nanotechnology is revolutionizing this landscape, offering innovative solutions for vaccine design, delivery, and optimization. This manuscript examines the transformative impact of AI and nanotechnology on advancing vaccine development, highlighting their synergistic effect in overcoming traditional limitations. AI, particularly machine learning (ML) and deep learning (DL) algorithms, facilitates rapid identification of immunogenic antigens and epitopes by analyzing vast genomic, proteomic, and immunological datasets. These computational tools optimize vaccine design by predicting antigen stability, immunogenicity, and efficacy, as exemplified by the expedited development of COVID-19 vaccines. Nanotechnology complements these advancements by providing engineered nanoparticles (NPs), including liposomes, polymeric NPs, and biomimetic systems, that enhance antigen delivery, stability, and immune activation. Innovations such as virus-like particles (VLPs) and immune-stimulating complexes (ISCOMs) further enhance vaccine safety and efficacy by mimicking natural infection processes to trigger robust, targeted immune responses. Integrating AI and nanotechnology presents remarkable opportunities for developing personalized immunization strategies. AI algorithms can assess individual immune profiles to design customized vaccines, while nanotechnology enables precise delivery and controlled release of antigens. This interdisciplinary approach accelerates vaccine development, ensuring both safety and efficacy, and lays the foundation for universal vaccines and cancer vaccines that target complex pathogens and non-infectious diseases. Together, AI and nanotechnology herald a new era in vaccinology, enabling the development of vaccines that are faster, more precise, and highly adaptable to emerging and complex health challenges. |
| format | Artículo científico |
| id | pubmed_40886810 |
| institution | PubMed |
| language | en |
| publishDate | 2025 |
| publisher | International journal of pharmaceutics |
| record_format | pubmed |
| spellingShingle | Applications of artificial intelligence and nanotechnology in vaccine development. Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad Humans Artificial Intelligence Nanotechnology Vaccine Development COVID-19 Vaccines COVID-19 Animals Nanoparticles SARS-CoV-2 Applications of artificial intelligence and nanotechnology in vaccine development. Bahrami, Yadollah Bolideei, Mansoor Mohammadzadeh, Sara Gahrouei, Razieh Bahrami Mohebbi, Elham Haider, Khawaja Husnain Barzigar, Rambod Mehran, Mohammad Javad Humans Artificial Intelligence Nanotechnology Vaccine Development COVID-19 Vaccines COVID-19 Animals Nanoparticles SARS-CoV-2 Vaccines have long been crucial in safeguarding public health by preventing and controlling infectious diseases. However, traditional vaccine development methods face challenges in efficiency, cost, and response time to emerging pathogens. Recent progress in art AI and nanotechnology is revolutionizing this landscape, offering innovative solutions for vaccine design, delivery, and optimization. This manuscript examines the transformative impact of AI and nanotechnology on advancing vaccine development, highlighting their synergistic effect in overcoming traditional limitations. AI, particularly machine learning (ML) and deep learning (DL) algorithms, facilitates rapid identification of immunogenic antigens and epitopes by analyzing vast genomic, proteomic, and immunological datasets. These computational tools optimize vaccine design by predicting antigen stability, immunogenicity, and efficacy, as exemplified by the expedited development of COVID-19 vaccines. Nanotechnology complements these advancements by providing engineered nanoparticles (NPs), including liposomes, polymeric NPs, and biomimetic systems, that enhance antigen delivery, stability, and immune activation. Innovations such as virus-like particles (VLPs) and immune-stimulating complexes (ISCOMs) further enhance vaccine safety and efficacy by mimicking natural infection processes to trigger robust, targeted immune responses. Integrating AI and nanotechnology presents remarkable opportunities for developing personalized immunization strategies. AI algorithms can assess individual immune profiles to design customized vaccines, while nanotechnology enables precise delivery and controlled release of antigens. This interdisciplinary approach accelerates vaccine development, ensuring both safety and efficacy, and lays the foundation for universal vaccines and cancer vaccines that target complex pathogens and non-infectious diseases. Together, AI and nanotechnology herald a new era in vaccinology, enabling the development of vaccines that are faster, more precise, and highly adaptable to emerging and complex health challenges. |
| title | Applications of artificial intelligence and nanotechnology in vaccine development. |
| topic | Humans Artificial Intelligence Nanotechnology Vaccine Development COVID-19 Vaccines COVID-19 Animals Nanoparticles SARS-CoV-2 |
| url | https://pubmed.ncbi.nlm.nih.gov/40886810/ |